RecruitingNot ApplicableNCT05863754

Grasp-Release Assessment of a Networked Neuroprosthesis Device

Sponsor

MetroHealth Medical Center

Enrollment

13 participants

Start Date

Jan 23, 2022

Study Type

INTERVENTIONAL

Conditions

Spinal Cord Injuries Spinal Cord Injury Cervical Spinal Cord Injury at C5-C7 Level

Summary

The overall objective of this trial is to characterize the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity (NP-UE) in individuals living with cervical SCI.

Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Networked Neuroprosthesis Device for people with spinal cord injuries, spinal cord injury cervical, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 16 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENetworked Neuroprosthesis Device

The Networked Neuroprosthesis Device is an implantable, configurable neuromodulation platform that provides functional movement by the coordinated activation of peripheral neural pathways activating innervated paralyzed muscles, and sensing of physiological signals.